Market Closed -
OTC Markets
03:34:26 2024-04-26 pm EDT
|
5-day change
|
1st Jan Change
|
0.08
USD
|
-6.43%
|
|
+3.90%
|
-39.39%
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
---|
Capitalization
1 |
432.6
|
592.8
|
112.6
|
31.28
|
3.172
|
3.172
|
-
|
Enterprise Value (EV)
1 |
432.6
|
592.8
|
112.6
|
31.28
|
3.172
|
3.172
|
3.172
|
P/E ratio
|
-3.63
x
|
-5.98
x
|
-1.03
x
|
-0.32
x
|
-0.04
x
|
-0.09
x
|
-0.09
x
|
Yield
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Capitalization / Revenue
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
EV / Revenue
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
EV / EBITDA
|
-
|
-6,853,175
x
|
-1,064,427
x
|
-
|
-
|
-
|
-
|
EV / FCF
|
-6,978,354
x
|
-
|
-1,172,444
x
|
-383,273
x
|
-
|
-
|
-
|
FCF Yield
|
-0%
|
-
|
-0%
|
-0%
|
-
|
-
|
-
|
Price to Book
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Nbr of stocks (in thousands)
|
27,961
|
36,707
|
37,151
|
39,067
|
39,653
|
39,653
|
-
|
Reference price
2 |
15.47
|
16.15
|
3.030
|
0.8006
|
0.0800
|
0.0800
|
0.0800
|
Announcement Date
|
3/11/20
|
2/25/21
|
3/3/22
|
3/29/23
|
-
|
-
|
-
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
---|
Net sales
1 |
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
EBITDA
|
-
|
-
|
-86.5
|
-105.8
|
-
|
-
|
-
|
-
|
EBIT
1 |
-
|
-72.57
|
-88.88
|
-110.3
|
-98.3
|
-81.85
|
-44.46
|
-50.69
|
Operating Margin
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Earnings before Tax (EBT)
1 |
-
|
-67.48
|
-86.33
|
-109.3
|
-97.16
|
-80.04
|
-42.99
|
-48.15
|
Net income
1 |
-37.94
|
-67.48
|
-86.34
|
-109.3
|
-97.16
|
-80.04
|
-42.99
|
-48.15
|
Net margin
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
EPS
2 |
-108.0
|
-4.260
|
-2.700
|
-2.950
|
-2.520
|
-2.040
|
-0.8600
|
-0.8650
|
Free Cash Flow
|
-
|
-61.98
|
-
|
-96.01
|
-81.61
|
-
|
-
|
-
|
FCF margin
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
FCF Conversion (EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
FCF Conversion (Net income)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Dividend per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
4/24/19
|
3/11/20
|
2/25/21
|
3/3/22
|
3/29/23
|
-
|
-
|
-
|
Fiscal Period: December |
2021 Q2
|
2021 Q3
|
2021 Q4
|
2022 Q1
|
2022 Q2
|
2022 Q3
|
2022 Q4
|
2023 Q1
|
2023 Q2
|
2023 Q3
|
2023 Q4
|
2024 Q1
|
2024 Q2
|
2024 Q3
|
2024 Q4
|
---|
Net sales
1 |
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
EBITDA
|
-27.07
|
-26.1
|
-28.14
|
-25.67
|
-28.03
|
-21.93
|
-
|
-21.53
|
-18.47
|
-14.88
|
-
|
-
|
-
|
-
|
-
|
EBIT
1 |
-27.07
|
-27.52
|
-29.51
|
-25.67
|
-28.03
|
-23.29
|
-21.3
|
-21.53
|
-19.75
|
-15.79
|
-14.33
|
-9
|
-9.8
|
-10
|
-10.8
|
Operating Margin
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Earnings before Tax (EBT)
1 |
-26.67
|
-27.36
|
-29.52
|
-24.88
|
-27.88
|
-23.06
|
-21.34
|
-21.01
|
-19.19
|
-36.22
|
-13.93
|
-8.8
|
-9.5
|
-9.8
|
-10.5
|
Net income
1 |
-26.68
|
-27.36
|
-29.52
|
-24.88
|
-27.88
|
-23.06
|
-21.34
|
-21.01
|
-19.19
|
-36.22
|
-13.93
|
-8.8
|
-9.5
|
-9.8
|
-10.5
|
Net margin
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
EPS
2 |
-0.7200
|
-0.7400
|
-0.7900
|
-0.6500
|
-0.7200
|
-0.6000
|
-0.5500
|
-0.5400
|
-0.4900
|
-0.9200
|
-0.3500
|
-0.2200
|
-0.1500
|
-0.1500
|
-0.1600
|
Dividend per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
8/11/21
|
11/2/21
|
3/3/22
|
5/11/22
|
8/8/22
|
11/10/22
|
3/29/23
|
5/10/23
|
8/10/23
|
11/14/23
|
-
|
-
|
-
|
-
|
-
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
---|
Net Debt
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Net Cash position
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Leverage (Debt/EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Free Cash Flow
|
-
|
-62
|
-
|
-96
|
-81.6
|
-
|
-
|
-
|
ROE (net income / shareholders' equity)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
ROA (Net income/ Total Assets)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Assets
1 |
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Book Value Per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Cash Flow per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Capex
|
-
|
3.45
|
5.03
|
35.1
|
0.89
|
-
|
-
|
-
|
Capex / Sales
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
4/24/19
|
3/11/20
|
2/25/21
|
3/3/22
|
3/29/23
|
-
|
-
|
-
|
Last Close Price
0.08
USD Average target price
2
USD Spread / Average Target +2,400.00% Consensus |
1st Jan change
|
Capi.
|
---|
| -39.39% | 3.17M | | -2.31% | 103B | | +0.56% | 95.28B | | +1.69% | 22.15B | | -17.37% | 21.02B | | -9.30% | 18.15B | | -41.01% | 16.73B | | -14.85% | 16.05B | | +3.21% | 13.68B | | +33.54% | 12.17B |
Bio Therapeutic Drugs
|